June 28, 2025· 41 min

The Biotech Start-Up Making Vaccines for Bees and Shrimp

Orality
Model
81%
Oral-dominant (speeches, podcasts, storytelling)

Speaker Breakdown

HostTracy Alloway(1,447 words)
M:94%
HostJoe Weisenthal(1,225 words)
M:94%
GuestAnnette Kleiser(3,765 words)
M:28%

Oral Indicators

Agonistic34%
very, huge, clearly
Engagement83%
you, our, your
Memory Aids100%
listen, now, so
Repetition100%
know (111x), it's (64x), they (55x)
Parallelism85%
So you are about to listen to ..., So you might hear us reference..., And I'm Joe Wiesenthal....
Sound Patterns83%
64 question(s), alliteration: "markets move", alliteration: "barclays brief"
Formulaic Phrases3%
i mean

Literate Indicators

Hedging10%
could, might, quite
Passive Voice6%
was called, are protected, is protected
Abstract Nouns18%
investment, information, volatility
Subordination5%
because, though, while
Sentence Length32%
Avg: 13.0 words/sentence
Word Complexity48%
investment, analyze, anticipate
Academic Markers0%
Impersonal Style17%
642 personal pronouns found
Descriptive Style83%
monthly, carefully, heavily

Description

Think of a biotech company and most people will think of a business trying to come up with cures and treatments for human illnesses. There's not a lot of discussion about companies trying to do the same for animals, insects, or even... crustaceans. And yet, healthy animals are a key part of the ecosystem and important for our food supply. In this episode we speak to Annette Kleiser, CEO of Dalan Animal Health, which has developed the world's first vaccine for bees and is now working on a similar treatment to protect shrimp. We talk about the development and regulatory process, plus what it's actually like raising money for a brand new business. Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots See omnystudio.com/listener for privacy information.